title: Barriers to human immunodeficiency virus testing of tuberculosis patients in Thailand, 2004-2007.
abstract: METHODS
  Tuberculosis (TB) clinics in five provinces and one national referral hospital in Thailand.
  
  
  OBJECTIVE
  To identify risk factors for TB patients not receiving human immunodeficiency virus (HIV) pre-test counseling and testing in Thailand.
  
  
  METHODS
  We collected data on TB patients treated at participating facilities from 2004 to 2007. Patients with known HIV status at the time of TB diagnosis were excluded from the analysis. We performed multivariate logistic regression to determine patient and facility characteristics associated with HIV counseling and testing.
  
  
  RESULTS
  Of 15 903 TB patients, HIV pre-test counseling was provided to 13 604 (86%). HIV testing was provided to 11 702 (86%) of those counseled. Of 6141 patients with unknown HIV status, 2323 (38%) were treated in facilities that provide HIV testing in TB clinics compared with 6412 (58%) of 11 003 non-HIV-infected and 3814 (62%) of 6121 HIV-infected patients (P < 0.05). In multivariate analysis, patients treated in facilities in which HIV testing of TB patients was performed somewhere other than the TB clinic were significantly less likely to undergo HIV pre-test counseling (adjusted OR 1.55, 95%CI 1.28-1.86).
  
  
  CONCLUSIONS
  In Thailand, providing HIV testing directly in TB clinics, rather than in other settings, may increase the proportion of TB patients with known HIV status.
authors.affiliation: Thailand Ministry of Public Health, US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
authors.forename: A
authors.initials: A
authors.lastname: Anuwatnonthakate
authors.forename: S X
authors.initials: SX
authors.lastname: Jittimanee
authors.forename: J
authors.initials: J
authors.lastname: Cain
authors.forename: S
authors.initials: S
authors.lastname: Nateniyom
authors.forename: W
authors.initials: W
authors.lastname: Wattanaamornkiat
authors.forename: S
authors.initials: S
authors.lastname: Komsakorn
authors.forename: S
authors.initials: S
authors.lastname: Moolphate
authors.forename: P
authors.initials: P
authors.lastname: Banyati
authors.forename: N
authors.initials: N
authors.lastname: Chiengsorn
authors.forename: P
authors.initials: P
authors.lastname: Limsomboon
authors.forename: S
authors.initials: S
authors.lastname: Kaewsa-Ard
authors.forename: J K
authors.initials: JK
authors.lastname: Varma
mesh_terms: D000293:Adolescent; D000328:Adult; D003376:Counseling / Q000458:organization & administration*; D005260:Female; D005500:Follow-Up Studies; D006678:HIV / Q000276:immunology*; D015483:HIV Antibodies / Q000032:analysis*; D015658:HIV Infections / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D013785:Thailand / Q000453:epidemiology; D014376:Tuberculosis / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology; D055815:Young Adult
chemical_list: D015483:HIV Antibodies